Invega vs. Geodon

See how Invega and Geodon compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Invega is a once-daily tablet, while Geodon must be taken twice daily with a substantial meal for the medication to absorb properly.

  • Both drugs carry a boxed warning about increased mortality in elderly patients with dementia-related psychosis and are not approved for that use.

  • Geodon has a higher reported rate of extrapyramidal symptoms and a greater risk of QT prolongation, while Invega offers long-acting injectable options Geodon does not.

Invega vs. Geodon Drug Summary

Invega

Invega (paliperidone) is an atypical antipsychotic taken once daily as an extended-release tablet. It is used to treat schizophrenia and schizoaffective disorder by adjusting dopamine and serotonin activity in the brain.

Geodon

Geodon (ziprasidone) is also an atypical antipsychotic, taken as a twice-daily oral capsule with food, or as a short-term injection for acute agitation. It treats schizophrenia along with both the manic and maintenance phases of bipolar disorder.

Invega vs. Geodon Side Effects

Invega

Most common
Extrapyramidal symptoms (13%)
Akathisia (12%)
Headache (10%)
Sedation/somnolence (7%)

Geodon

Most common
Extrapyramidal symptoms (31%)
Akathisia (≥5%)
Headache (13-18%)
Somnolence (14-20%)

Invega vs. Geodon Dosage

Invega

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 3 mg once daily At the start
Maximum dose 12 mg once daily If needed
Dose changes 3 increases As tolerated

Geodon

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 20 mg twice daily At the start
Maximum dose 20-80 mg twice daily If needed
Dose changes 1 increase As tolerated

Invega vs. Geodon Indications

Invega

Invega is FDA-approved for schizophrenia in adults and adolescents 12 and older, and for schizoaffective disorder in adults, either alone or alongside mood stabilizers or antidepressants. It is not approved for treating psychosis related to dementia.

  • Schizophrenia in adults and adolescents (12-17)

  • Schizoaffective disorder in adults, alone or with mood stabilizers/antidepressants

  • Not approved for dementia-related psychosis

Geodon

Geodon is FDA-approved for schizophrenia in adults, for acute manic or mixed episodes of bipolar disorder, and for longer-term bipolar maintenance when combined with lithium or valproate. Its injectable form is also used for acute agitation in schizophrenia, but like Invega, it is not approved for dementia-related psychosis.

  • Schizophrenia in adults

  • Acute manic or mixed episodes of bipolar disorder

  • Maintenance bipolar treatment with lithium or valproate

Invega vs. Geodon Pros and Cons

Invega

Invega's once-daily tablet and range of long-acting injectable options make it a flexible choice for people who struggle with daily pills. It carries a lower relative risk of QT prolongation than Geodon, though it still requires monitoring and kidney-based dose adjustments.

Pros

  • Once-daily dosing simplifies the routine

  • Long-acting injectable versions available (monthly, every 3 months, or every 6 months)

  • Lower relative risk of significant QT prolongation than Geodon

  • No food requirement for the medication to absorb properly

Cons

  • Higher reported rates of insomnia and akathisia than Geodon's label

  • Requires dose adjustments based on kidney function

  • Tablet's outer shell may appear intact in stool, which can alarm patients

  • Not approved for any bipolar disorder indication

Geodon

Geodon covers a broader range of approved uses, including both acute and maintenance treatment of bipolar disorder, but it must be taken with food and carries a higher risk of QT prolongation than Invega. It also requires monitoring for rarer but serious blood and skin reactions.

Pros

  • FDA-approved for both acute and maintenance bipolar disorder, not just schizophrenia

  • Available as a short-term injectable for acute agitation

  • No renal dose adjustments required once established

  • Lower reported rate of insomnia than Invega

Cons

  • Must be taken twice daily with a substantial meal to absorb properly

  • Greater capacity to prolong the QT interval than many other antipsychotics

  • Carries added risk of DRESS syndrome and blood cell abnormalities like agranulocytosis

  • Not approved for use in adolescents

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.